Log In Sign Up Premium
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘NASDAQ:ONXX’

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease...

Keep Reading →

September 23 - News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech

With all of the heat generated by this biotech and its stock, it pays to pay attention to what Celgene Corporation (NASDAQ:CELG) says.

Keep Reading →

September 16 - News - Comments

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.

Keep Reading →

September 10 - News - Comments

Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)

As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...

Keep Reading →

September 9 - News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

The big biotech announced on Thursday that updated results from its phase 3 study of Pomalyst in treating relapsed or refractory multiple myeloma had been published online in ...

Keep Reading →

September 5 - News - Comments

Astex Pharmaceuticals, Inc. (ASTX) Becomes the Latest Biotech Domino to Fall

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) is being scooped up by Tokyo-based Otsuka Pharmaceuticals.

Keep Reading →

September 5 - News - Comments

Pharma News Highlights: VIVUS, Inc. (VVUS) New CEO, Arena Pharmaceuticals, Inc. (ARNA)’s Rating, Amgen, Inc. (AMGN)’s Acquisition

VIVUS, Inc.

Keep Reading →

September 5 - News - Comments

Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

September 1 - News - Comments

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Monday’s Best Stocks

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...

Keep Reading →

August 27 - News - Comments

Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Onyx Pharmaceuticals, Inc. (ONXX): This Biotech Envisions Green

After a second offer, Amgen, Inc. (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc.

Keep Reading →

August 27 - News - Comments

The Amgen, Inc. (AMGN)-Onyx Pharmaceuticals, Inc. (ONXX) Deal Should Make All Biotech Investors Happy

While that's certainly not what Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors were hoping for -- at one point, after Amgen, Inc.

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX), NASDAQ OMX Group, Inc. (NDAQ): Deals, Not Data, Drive Dow Today

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (AMGN) and Onyx Pharmaceuticals, Inc. (ONXX): Half a Billion Dollars’ Worth of Drama

A finale has at last arrived for the biotech drama of summer 2013. Amgen, Inc. (NASDAQ:AMGN) announced yesterday that it will buy Onyx Pharmaceuticals, Inc.

Keep Reading →

August 26 - News - Comments

What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)

In the 21st century investor’s toolkit, there are tons of metrics market participants can use to track the equity markets.

Keep Reading →

August 26 - News - Comments

What Is Amgen, Inc. (AMGN) Getting For Its Money?

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...

Keep Reading →

August 26 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up

In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.

Keep Reading →

August 26 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Microsoft Corporation (MSFT): Stocks to Watch Closely Today

Since the first day of the week can predict the flow of the whole week, it is particularly crucial to focus on Monday news and events.

Keep Reading →

August 26 - News - Comments

Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)

In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?

At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc.

Keep Reading →

August 24 - News - Comments

Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?

If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.

Keep Reading →

August 23 - News - Comments

Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?

There's been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (NASDAQ:AMGN).

Keep Reading →

August 23 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Celgene Corporation (CELG)’s Multiple Myeloma Powerhouse

Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of pomalidomide, known in the...

Keep Reading →

August 22 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech’s Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)’s Huge Week

Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...

Keep Reading →

August 19 - News - Comments

Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar

The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.

Keep Reading →

August 16 - News - Comments

Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

August 12 - News - Comments

Amgen, Inc. (AMGN), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): A Closer Look at the Battle Over Cancer Treatments

Over the past year, the battle over cancer treatments has heated up considerably. Big pharma companies such as Amgen, Inc. (NASDAQ:AMGN), Pfizer Inc.

Keep Reading →

August 7 - News - Comments

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July.

Keep Reading →

August 6 - News - Comments

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): This Orphan Drug Company Only Appears Expensive

In the last couple of months, we saw two big offers being made - and rejected - in the biotech sector.

Keep Reading →

August 5 - News - Comments

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow.

Keep Reading →

July 26 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout.

Keep Reading →

July 24 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Why Getting Rich Quick Doesn’t (Always) Pay

We have a bona fide biotech soap opera going on these days. Spurned love. Possible romance. Disgruntled suitor. And, of course, the unknown villain.

Keep Reading →

July 24 - News - Comments

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), Onyx Pharmaceuticals, Inc. (ONXX), Seattle Genetics, Inc. (SGEN): Betting on Blockbusters

Global biotechnology industry revenue is expected to reach $262 billion this year showing growth of around 12.7% year over year.

Keep Reading →

July 22 - News - Comments

Amgen, Inc. (AMGN)’s Acquisition Ambition Leads Biotechs’ Rise

Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...

Keep Reading →

July 22 - News - Comments

Celgene Corporation (CELG): Expanding Labels to Expand Margins

In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company's financial health.

Keep Reading →

July 19 - News - Comments

Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)

The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.

Keep Reading →

July 19 - News - Comments

Celgene Corporation (CELG): Can This Biotech Go Even Higher?

Celgene Corporation (NASDAQ:CELG) has emerged as the leading treatment provider for blood cancer.

Keep Reading →

July 19 - News - Comments

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): A Fundamentally Strong Biotech Stock

Celgene Corporation (NASDAQ:CELG) surged 7% on Thursday, July 11, 2013 on news that the Phase III trials of Revlimid /dexamethasone combination showed that it could be an initial...

Keep Reading →

July 18 - News - Comments

Is Pfizer Inc. (PFE) Destined for Greatness?

Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.

Keep Reading →

July 18 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year

Chances are that a few biotech companies will be scooped up by larger players over the coming months.

Keep Reading →

July 17 - News - Comments

Revlimid Results Rev Up Celgene Corporation (CELG)

Good news seems to find its way to Celgene Corporation (NASDAQ:CELG)'s door frequently these days.

Keep Reading →

July 11 - News - Comments

Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?

Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN).

Keep Reading →

July 10 - News - Comments

Who Is the Best Suitor for Onyx Pharmaceuticals, Inc. (ONXX)?

Cancer-drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) recently rejected an $8.7 billion unsolicited acquisition offer from Amgen, Inc. (NASDAQ:AMGN).

Keep Reading →

July 10 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Pharmacyclics, Inc. (PCYC): Will This Biotech Acquisition Buzz Lead to More Buyouts?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is trading higher after rejecting a takeover bid.

Keep Reading →

July 9 - News - Comments

Amgen, Inc. (AMGN) Stirs the Pot in the Cancer-Related Sector

Several companies are fighting to be the first to release a treatment or cure for cancer that is a game-changer, and this battle has created a field where firms are looking to...

Keep Reading →

July 8 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Achillion Pharmaceuticals, Inc. (ACHN): This Week in Biotech

With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

July 8 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week

While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs.

Keep Reading →

July 8 - News - Comments

How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?

The promising cancer developer confirmed over the weekend that Amgen had made an offer to acquire Onyx for $120 per share, a 38.2% premium above Friday's close.

Keep Reading →

July 5 - News - Comments

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Is This Biopharmaceutical Stock Still a Buy?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has recently experienced a significant jump of nearly 51.3% in only one trading day from $86.82 per share to $131.30 per share.

Keep Reading →

July 5 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Is This A Good Acquisition For All?

For the second day in a row, the hot topic in the market is the bidding war for Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX). After rejecting Amgen, Inc.

Keep Reading →

July 3 - News - Comments

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Avoid This Biotech Investment, For Now

Mergers and acquisitions have always been a big part of the biotechnology industry, and the patent cliff has further increased M&A activity.

Keep Reading →

July 3 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Lists

12 Countries that Produce the Best Tea in the World

12 Countries that Produce the Best Tea in the World

15 Least Developed Countries in Latin America

15 Least Developed Countries in Latin America

25 Least Developed Countries in Africa

25 Least Developed Countries in Africa

25 Least Developed Countries in Asia

25 Least Developed Countries in Asia

20 Best For-Profit Colleges in the US

20 Best For-Profit Colleges in the US

25 Most Viewed YouTube Videos of All Time

25 Most Viewed YouTube Videos of All Time

5 Most Viewed YouTube Videos of All Time

5 Most Viewed YouTube Videos of All Time

16 Largest Photography Companies In The World

16 Largest Photography Companies In The World

15 States with the Highest Tax Revenue Per Capita

15 States with the Highest Tax Revenue Per Capita

25 Fastest Cars In The World

25 Fastest Cars In The World

25 Richest Countries with the Most Billionaires

25 Richest Countries with the Most Billionaires

25 Most Famous Companies in the World

25 Most Famous Companies in the World

5 Most Famous Companies in the World

5 Most Famous Companies in the World

20 Least Populated States in America

20 Least Populated States in America

5 Least Populated States in America

5 Least Populated States in America

12 Biggest Industrial Software Companies in the World

12 Biggest Industrial Software Companies in the World

21 Best Dating Apps of 2023

21 Best Dating Apps of 2023

15 Largest Steel Producing Countries in the World

15 Largest Steel Producing Countries in the World

The 30 Most Famous Yale Students Of All Time

The 30 Most Famous Yale Students Of All Time

20 Most Valuable Swedish Companies In The World

20 Most Valuable Swedish Companies In The World

Top 25 Smartest Companies To Buy According To Hedge Funds

Top 25 Smartest Companies To Buy According To Hedge Funds

15 Most Valuable Retail Companies In The World

15 Most Valuable Retail Companies In The World

15 Largest Ophthalmology Companies in the World

15 Largest Ophthalmology Companies in the World

19 Biggest Outdoor Brands and Companies

19 Biggest Outdoor Brands and Companies

15 Countries That Produce The Most Hydropower

15 Countries That Produce The Most Hydropower

15 Biggest Neuroscience Companies in the World

15 Biggest Neuroscience Companies in the World

15 Countries With The Largest Refining Capacity

15 Countries With The Largest Refining Capacity

Top 20 Financial Cities in the World

Top 20 Financial Cities in the World

Top 5 Financial Cities in the World

Top 5 Financial Cities in the World

25 Least Developed Countries in Europe

25 Least Developed Countries in Europe

15 Cheapest New Cars For 2023

15 Cheapest New Cars For 2023

25 Companies That Make the Most Money in the World

5 Companies That Make the Most Money in the World

15 Largest Australian Companies by Revenue

15 Largest Australian Companies by Revenue

5 Largest Australian Companies by Revenue

5 Largest Australian Companies by Revenue

25 Largest British Companies by Revenue

25 Largest British Companies by Revenue

Top 20 Oil Importing Countries in 2023

Top 20 Oil Importing Countries in 2023

21 Largest Italian Companies by Market Cap

21 Largest Italian Companies by Market Cap

17 Most Valuable E-Commerce Companies in the World

17 Most Valuable E-Commerce Companies in the World

Top 20 Oil Exporting Countries in 2023

Top 20 Oil Exporting Countries in 2023

Top 5 Oil Exporting Countries in 2023

Top 5 Oil Exporting Countries in 2023

16 Largest Indian Banks by Assets

16 Largest Indian Banks by Assets

5 Largest Indian Banks by Assets

5 Largest Indian Banks by Assets

25 Most Powerful Countries in Europe

25 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

11 Largest Property Management Companies in the US

11 Largest Property Management Companies in the US

30 of the World's Most Valuable Private Companies

30 of the World's Most Valuable Private Companies

25 Largest Privately Held Companies in America

25 Largest Privately Held Companies in America

13 Biggest Eyewear Companies in the World

13 Biggest Eyewear Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use CCPA - Do Not Sell My Information. ©2022 Koala Guide LLC.